Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2005;13(5-6):441-54.
doi: 10.1163/156856005774649377.

Comparative study of anti-inflammatory and ulcerogenic activities of different cyclo-oxygenase inhibitors

Affiliations
Comparative Study

Comparative study of anti-inflammatory and ulcerogenic activities of different cyclo-oxygenase inhibitors

Alessandra Gambero et al. Inflammopharmacology. 2005.

Abstract

The aim of the present work was to study the in vivo anti-inflammatory activity of six NSAIDs, ibuprofen, diclofenac, nimesulide, meloxicam, celecoxib and rofecoxib, using the rat air-pouch model of inflammation to characterize the ability of these drugs to induce gastric damage and PGE(2) inhibition. Selective compounds were observed to have no ulcerogenic properties at anti-inflammatory doses; however, these drugs were weaker inhibitors of several inflammatory aspects such as cell influx and exudate formation. In contrast, the non-selective and preferential compounds present anti-inflammatory properties at lower doses than presented by selective drugs. At anti-inflammatory doses, only meloxicam and ibuprofen produced gastric damage and inhibition of PGE(2) synthesis, suggesting that ulcerogenic properties of NSAIDs cannot be predicted by their selectivity index, since meloxicam demonstrates ulcerogenic properties despite its preferential profile.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Inflamm Res. 2002 Dec;51(12):603-10 - PubMed
    1. J Pharmacol Exp Ther. 1999 Aug;290(2):551-60 - PubMed
    1. Br J Pharmacol. 1999 Mar;126(5):1200-4 - PubMed
    1. Arthritis Rheum. 1997 Jan;40(1):143-53 - PubMed
    1. Br J Clin Pharmacol. 2002 Mar;53(3):255-65 - PubMed

Publication types

MeSH terms

LinkOut - more resources